Evidence summary of human milk fortifier in preterm infants

• Published in: Translational pediatrics 2021-11, Vol.10 (11), p.3058-3067
• Main Authors: Gu, Xin, Shi, Xiaofen, Zhang, Limin, Zhou, Ying, Cai, Yinghua, Jiang, Wujia, Zhou, Qunyan
• Format: Article
• Language: English
• Subjects: Original
• ISSN: 2224-4344; 2224-4336; 2224-4344
• DOI: 10.21037/tp-21-476

To search for and collect evidence on human milk fortifier in preterm infants, and to summarize the latest and best evidence, so as to provide reference for clinical work. We searched the databases of UpToDate, American Guide Network, Cochrane Library, Joanna Briggs Institute (JBI), PubMed, ResearchGate, China National Knowledge Infrastructure (CNKI), Wan Fang, Chinese Biology Medicine disc (CBM), and Yi Maitong, and collected relevant guidelines, systematic reviews, evidence summaries, expert consensuses, and randomized controlled trials (RCTs). The retrieval time limit was from the database establishment to July 2021. The quality of the literature was independently evaluated by 2 researchers, who then extracted and summarized the evidence from qualifying articles. A total of 16 articles were selected, including 3 guidelines, 3 systematic reviews, 5 expert consensuses, 3 RCTs, and 1 best practice guideline, including indications, time for usage, methods, monitoring and management, time of cessation, health education, and post-discharge feeding. This study summarized the best evidence for human milk fortifier in preterm infants. Medical staff should assess the specific clinical conditions and parental wishes when applying the best evidence to ensure the effectiveness and safety of human milk fortifier, thus improving the quality of clinical nursing.